Overexpression of latent transforming growth factor-β1 (TGF-β1) binding protein 1 (LTBP-1) in association with TGF-β1 in ovarian carcinoma

Japanese Journal of Cancer Research

Volumn 92, Issue 5, 2001, Pages 506-515

  Higashi, Tomomi ^a   Sasagawa, Toshiyuki ^a   Inoue, Masaki ^a   Oka, Rie ^a   Shuangying, Leng ^a   Saijoh, Kiyofumi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

LTBP 1; Ovarian carcinoma; Overexpression; TGF 1

Indexed keywords

BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA1 BINDING PROTEIN 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; COLLOID CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYSTADENOMA; EXTRACELLULAR MATRIX; FEMALE; GENE ISOLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE DISPLAY; IMMUNOREACTIVITY; OVARY CARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SEROUS ADENOCARCINOMA; STROMA; WESTERN BLOTTING;

ADENOCARCINOMA, MUCINOUS; BLOTTING, WESTERN; CARRIER PROTEINS; CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA, MUCINOUS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034987333     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01123.x     Document Type: Article

References (36)

1. Latent high molecular weight complex of transforming growth factor β1; purification from human platelets and structural characterization
2. TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences
3. Cellular and extracellular biology of the latent transforming factor-β binding proteins
4. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β1 binding protein
5. Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1
6. Mammary tumor suppression by transforming growth factor β1 transgene expression
7. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
8. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential
9. Expression of dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas
10. Transforming growth factor-beta 1: Differential effects on multiple myeloma versus normal B cells
11. 1 cDNA escapes immune surveillance
12. 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice
13. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β
14. Differential expression of nitric oxide synthase isoforms in form-deprived chick eyes
15. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1
16. Extracellular fibrillar structure of latent TGFβ binding protein-1: Role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart
17. Extracellular matrix-associated transforming growth factor-β: Role in cancer cell growth and invasion
18. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming factor-β binding protein-1 (LTBP-1) in a cell type-specific manner
19. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1
20. Synthesis of messenger RNAs for transforming factors α and β and the epidermal growth factor receptor by human tumors
21. Growth factor expression in normal, benign, and malignant breast tissue
22. Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming factors α and β1 in renal cell carcinoma
23. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma
24. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
25. Expression and prognostic significance of TGF-β isotypes, latent TGF-β1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms
26. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming factor β (TGF-β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the TGF-β
27. Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells
28. TGF-β signaling from cell membrane to nucleus through SMAD proteins
29. Efficient association of an amino-terminally extended form of human latent transforming growth factor-β binding protein with the extracellular matrix
30. The latent transforming growth factor-β-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium
31. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans
32. Immunolocalization of latent transforming growth factor-beta binding protein-1 (LTBP1) during mouse development: Possible roles in epithelial and mesenchymal cytodifferentiation